Clinical Studies

At Neko Health research is in our DNA, and we always aim to push the limits of technology and science, to create the best possible product and service for our members to stay ahead of their health.

In broad terms our research portfolio is setup to investigate and develop technologies and methods to enable preventive and proactive healthcare. Our belief is that most diseases does not just happen to, but rather develop within you. Therefore, our focus is aimed towards assessing the biological functions of the body and to detect when these functions are altered or lost, rather than detecting disease and damage that has already started. Not only do we believe this can enable us to stop disease from ever occurring, but that it can also provide means for improving life quality and longevity. Today, a lot of healthcare guidelines are based on population statistics, but what if the individual is not average? We strive to develop these methods, so that they assess the specific individual, at the specific point in time.

Today, we are running 6 clinical studies in Sweden:

• SCAPIS 2 – Spectrum: this is a sub-study part of the Swedish CardioPulmonarybioImage 2 Study (SCAPIS 2), which is one of the world's largest longitudinal studies for investigation of methods to prevent cardiovascular and pulmonary diseases. Our sub-study is setup to focus on the smallest vessels of the body, the so-called “micro-circulation”, and the mapping of their change in performance and function related to the development of disease. Not only does the scope include several novel and state-of-the-art optical imaging technologies, but also the latest in precision blood markers. We will try to map the chain of events that lead to disease, to know how and when to intervene before tissue or organ damage occur. Chronic inflammation and auto-immune responses are examples of root-cause conditions that will be investigated. This investigation takes place at the hospital of Danderyd, Sweden.Click here for more information
• SCAPIS 2 – Cardio: this is yet another sub-study of SCAPIS 2, where the focus is to investigate the correlation between cardiovascular disease and arterial stiffness and vascular aging, but also the exploration of detecting risk of heart failure or aortic valve disease, using a novel setup of sensors, including contactless laser and microwave radars. A setup that is optimized for a highly efficient and automatable workflow. This investigation takes place at the hospital of Danderyd, Sweden.Click here for more information
• MIND: The MIND study (Microangiopathy IN Diabetes) shares a lot of the technologies, methods and objectives with the SCAPIS 2 – Spectrum, but is focused on type 1 diabetes. We want to learn how the diabetes affects the vascular system in detail and understand what mechanisms that set the severity of the resulting complications, and what technologies, methods and markers that are best to detect and monitor these mechanisms to enable the best means of intervention. This investigation takes place at the hospital of Danderyd, Sweden.Click here for more information
• Spectrum-1: this study shares the core imaging technology with the SCAPIS 2 and MIND studies, but explores a simplified protocol with the focus on diabetes type 2, peripheral arterial disease (PAD) and skin cancer, by assessing the molecular composition and haemodynamics of the skin micro-circulation and its correlation disease and severity. The vision is a “virtual skin biopsy”. This study takes place in our Swedish Neko clinics and our own primary care clinic in Stockholm.Click here for more information
• Cardio Alpha: this study shares the core technology and objectives with the SCAPIS 2 – Cardio study but has a slightly broader scope. This study takes place in our Swedish Neko clinics and our own primary care clinic in Stockholm.Click here for more information
• DermaFlow Alpha The skin is our biggest organ that changes all the time and varies a lot from person to person. The skin often gives us clues about what is happening in other parts of the body, hence this study also has a good overlap with our other studies. The study is about evaluating the suitability of multi-modal imaging technology that virtually covers the entire body, to assess the potential of screening and early detection of disease. The multi-modal technology is based on camera systems, which can capture high-resolution colour images (visible spectrum), 3D, and thermal images (infrared spectrum). By studying the correlation and sensitivity between disease states, gradients, and asymmetries in collected image data, the potential can be evaluated. This study takes place in our Swedish Neko clinics and our own primary care clinic in Stockholm.Click here for more information

Research Partnerships

Neko Health invests in research and supports clinical studies. For more information and collaboration inquiries, please contact us.